Pfizer Inc. v. Alembic Limited
1:11-cv-01213
Overview
Parties
Defendant
Alembic Pharmaceuticals Limited NPE (University / Research)
Represented By
2 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN
Alembic Limited NPE (University / Research)
Represented By
3 Attorneys ListedSmith, Katzenstein, & Jenkins LLP
1000 West Street, Suite 1501, Wilmington, DE 19801
ADDRESS EXPIRED / UNKNOWN
ADDRESS EXPIRED / UNKNOWN
Plaintiff
Northwestern University NPE (University / Research)
Represented By
3 Attorneys ListedMcCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
C P Pharmaceuticals International CV Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Warner-Lambert Company LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Pfizer Inc. Operating Company
Represented By
9 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 16 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 6,197,819 B1 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 5,563,175 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,342,529 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,140,366 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,255,345 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,525,096 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,117,906 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,262,120 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,291,526 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,414,024 B1 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 2003022516 | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 61,869,290 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 88,608,092 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 6,428,593 A | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 89,991,897 A | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There is a single patent involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6197819
Gamma amino butyric acid analogs and optical isomers
|
Filed: 1995-04-11
Issued: 2001-03-06
|
Expired (Term Ended)
+1359d PTA
Expires: 2018-12-30
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
High PTA (+1359 days) / Cellect Scrutiny — Over 1359 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
2
Dispositive
0
Granted
0
Denied
0
Pending / Review
1
Motions by Category
Key Dispositive Motions & Rulings